Veracyte Announces Study Results for Percepta Bronchial Genomic Classifier May 18, 2015 Use of the diagnostic device lowers unnecessary invasive and risky surgeries on suspicious lung nodules or lesions, company says. Read More
Medtronic Announces TYRX Antibacterial Envelope Trial Results May 15, 2015 The device cuts down on major cardiac device site infections. Read More
Genomic Health Announces Study Results for Oncotype Prostate Diagnostic May 15, 2015 The test improves risk assessment by about 25 percent and cuts costs, company says. Read More
Medtronic’s Evera Clinical Trial Meets Endpoints May 14, 2015 The ICD’s ability to detect possibly dangerous heart rhythms and administer therapy is not affected by MRI scans, company says. Read More
ResMed Halts Sleep Apnea Trial Over Risks May 14, 2015 Preliminary analysis indicates a statistically higher cardiovascular risk for some heart failure patients undergoing the treatment. Read More
Lithoplasty Clinical Trial Demonstrates Positive Six-Month Results May 13, 2015 Freedom from reintervention was 100 percent at six months, the company claims. Read More
Debiotech Gains iSense Glucose Monitoring Option May 12, 2015 The devicemaker has gained the exclusive rights to iSense’s sensor technology. Read More
Trial Board for Sanuwave’s DermaPace Requests More Data May 11, 2015 The move comes as the board says the device is unlikely to meet its endpoint. Read More
Epigenomics Announces Results of Colorectal Cancer Test Adherence Trial May 8, 2015 More patients adhered with the blood-based test compared with fecal immunochemical tests. Read More
Medtronic Announces First In-Office Implant of Insertable Cardiac Monitor May 8, 2015 The implant is part of the RIO 2 study, which will compare in-office and hospital procedures. Read More
23andMe, Pfizer Collaborate to Study Lupus May 6, 2015 The companies aim to enroll 5,000 individuals with the disease by mid-2016. Read More
Stentys Wins CE Mark for Self-Apposing Coronary Stent May 4, 2015 The first-of-its-kind device will hit the market later this month, company says. Read More